It's a fair point that Teva wouldn't want MSB to starve. However, I think it's perhaps unlikely that they would pony up some $$ outside a contracted milestone payment, which as I say, would typically come with a significant achievement. Maybe MSB could issue new equity to Teva if they needed $$ outside of the existing agreement.
Pure speculation on my part of course.
Incidentally, a new report out from Roberts today on GVHD, which values MSB at $9.73 base. In his opinion, the downward trajectory of MSBs price since the all-time high is due to "primarily a reflection of market scepticism in the United States regarding the commercial prospects of regenerative medicine ahead of any meaningful Phase III data, combined with the fact that Mesoblast is the 'tall poppy' in the space with a market capitalisation north of a billion US dollars".
Amongst other risks, he cites "High burn rate" at no. 3
- Forums
- ASX - By Stock
- MSB
- Back Pain Results
Back Pain Results, page-24
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 14089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 24054 | 0.935 |
8 | 131583 | 0.930 |
4 | 65851 | 0.925 |
7 | 113334 | 0.920 |
9 | 97006 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 1100 | 1 |
0.950 | 19026 | 2 |
0.955 | 27000 | 2 |
0.960 | 32869 | 2 |
0.965 | 35384 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online